LOVE, R. By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer. Archives of Breast Cancer, p. 8-13, 28 Jan. 2021.